Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enming Xing

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Advanced Materials (Deerfield Beach, Fla.)|October 6, 2021
Cycloruthenated Self-Assembly with Metabolic Inhibition to Efficiently Overcome Multidrug Resistance in CancersJia Li, Leli Zeng, Zheng Wang, et al.
Cancers|August 14, 2025
Valine-Niclosamide for Treatment of Androgen Receptor Splice Variant-Positive Hepatocellular CarcinomaEmma J Hoelzen, Hanna S Radomska, Samuel K Kulp, et al.
Cell Reports. Medicine|September 5, 2024
Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastomaYaogang Zhong, Feng Geng, Logan Mazik, et al.
Cancer Research|August 1, 2024
LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer TherapyShu Ning, Cameron M Armstrong, Enming Xing, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Advanced Materials (Deerfield Beach, Fla.)|October 6, 2021
Cycloruthenated Self-Assembly with Metabolic Inhibition to Efficiently Overcome Multidrug Resistance in CancersJia Li, Leli Zeng, Zheng Wang, et al.
Cancers|August 14, 2025
Valine-Niclosamide for Treatment of Androgen Receptor Splice Variant-Positive Hepatocellular CarcinomaEmma J Hoelzen, Hanna S Radomska, Samuel K Kulp, et al.
Cell Reports. Medicine|September 5, 2024
Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastomaYaogang Zhong, Feng Geng, Logan Mazik, et al.
Cancer Research|August 1, 2024
LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer TherapyShu Ning, Cameron M Armstrong, Enming Xing, et al.
Pageof 3